The Venture Codex Logo

The Venture Codex

Innomost

Kemirantie 1, Kokkola, 67900, Finland

Overview

Innomost is a Finnish startup founded in 2016 that develops and produces high‑quality, renewable ingredients from wooden side streams; its product portfolio includes Barkinno., Betuinno., and Suberinno. The company launched Betuinno.™ Betulin Top Quality Fine, a birch-bark‑derived white pigment intended to replace titanium dioxide across beauty, skin care, surfaces, coatings and suncream formulations. Betuinno.™ Betulin is described as biodegradable, vegan, non‑toxic, antioxidant and anti‑inflammatory, with skin‑healing, regenerating, moisturizing and largely anti‑allergenic properties. The ingredient is produced from upcycled birch bark sourced from certified forest industry side streams using an in‑house designed and patented production process that aims to minimize carbon footprint. Innomost completed a greenfield pilot plant at the inorganic chemical industry park in Kokkola (early 2023) to demonstrate its patented production technology and move toward commercial scale. Its products are already used on three continents, with clients including Lumene, and the company is pursuing international expansion into new industries. Innomost develops and produces high‑value bioactive ingredients from forest industry side streams, focusing on birch bark compounds for cosmetic and pharmaceutical applications. Its product portfolio includes birch charcoal powder, birch bark powder, betulin, suberin and azelaic acid. The company is led by CEO and founder Sami Selkälä and is based in Helsinki, Finland. Innomost plans to use new funding to set up a pilot plant in Kokkola to test and plan a subsequent industrial‑scale facility. The industrial plant is intended to produce 20 tonnes of birch bark products per year by 2023. The funds will also support R&D and expansion of the company’s international customer base.

Total raised
$7M
Funding rounds
2
Latest round
Equity
Latest activity
Apr 2024

Industries

  • Cosmetics
  • Personal Health
Visit website

Recent funding

  1. Equity

    Apr 2024

    $2M

  2. Equity

    Aug 2021

    $6M

Team